Back
Windtree Therapeutics Vs. Protalix BioTherapeutics Industry Stock Comparison
Sell
17
WINT
Windtree Therapeutics
Last Price:
0.50
Seasonality Move:
-6.99%
Buy
79
PLX
Protalix BioTherapeutics
Last Price:
1.70
Seasonality Move:
78.33%
Sell
17
Windtree Therapeutics (WINT)
is a Sell
Is Windtree Therapeutics a Buy, Sell or Hold?
- The current Windtree Therapeutics [WINT] share price is $0.51. The Score for WINT is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- WINT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
79
Protalix BioTherapeutics (PLX)
is a Buy
Is Protalix BioTherapeutics a Buy, Sell or Hold?
- The current Protalix BioTherapeutics [PLX] share price is $1.66. The Score for PLX is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- PLX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
WINT Stock Price Chart
What is Windtree Therapeutics's stock price today?
-
The Windtree Therapeutics share price today is $0.51
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and WINT is experiencing slight buying pressure.
PLX Stock Price Chart
What is Protalix BioTherapeutics's stock price today?
-
The Protalix BioTherapeutics share price today is $1.66
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLX is experiencing slight buying pressure.
WINT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.29 | Sell |
Relative Strength Index (14 RSI): | 28.37 | Sell |
Chaikin Money Flow: | 65293 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.52 - 0.86) | Sell |
Bollinger Bands (100): | (0.34 - 7.9) | Sell |
PLX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.14 | Buy |
Relative Strength Index (14 RSI): | 73.19 | Buy |
Chaikin Money Flow: | 48120 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.06 - 1.46) | Buy |
Bollinger Bands (100): | (0.95 - 1.25) | Buy |
WINT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.5 | Buy |
20-day SMA: | 0.63 | Sell |
50-day SMA: | 1.37 | Sell |
200-day SMA: | 4.73 | Sell |
8-day EMA: | 0.52 | Sell |
20-day EMA: | 0.68 | Sell |
50-day EMA: | 1.73 | Sell |
200-day EMA: | 10.76 | Sell |
PLX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.5 | Buy |
20-day SMA: | 1.32 | Buy |
50-day SMA: | 1.16 | Buy |
200-day SMA: | 1.19 | Buy |
8-day EMA: | 1.53 | Buy |
20-day EMA: | 1.36 | Buy |
50-day EMA: | 1.22 | Buy |
200-day EMA: | 1.23 | Buy |
Windtree Therapeutics Earnings Growth & WINT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $92.48 per share, and an increase next year of $0.25 per share.
Protalix BioTherapeutics Earnings Growth & PLX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Windtree Therapeutics Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Protalix BioTherapeutics Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |